Wednesday, September 9, 2026

HomeHealth NewsImproving immunotherapy responses to fight cancer with dual therapies

Improving immunotherapy responses to fight cancer with dual therapies

- Advertisement -

Anti–PD-1/anti-MIF improves survival and tumor responses. Credit: JCI Insight (2025). DOI: 10.1172/jci.insight.191539

Promising study in dual inhibition of PD1 and macrophage migration inhibitory factor

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed